Soligenix has entered into definitive agreements with institutional investors and certain members of the Company's management and Board of Directors to sell approximately $7.0M of the Company's securities, consisting of an aggregate of approximately 6.6 M shares of common stock at a price per share of $1.05 and 5-year warrants to purchase up to approximately 5.0 million shares of common stock with an exercise price of $1.65 per share. Maxim Group LLC served as placement agent for the offering.